407 related articles for article (PubMed ID: 19200178)
21. Calcitriol (1,25-dihydroxycholecalciferol) enhances paclitaxel antitumor activity in vitro and in vivo and accelerates paclitaxel-induced apoptosis.
Hershberger PA; Yu WD; Modzelewski RA; Rueger RM; Johnson CS; Trump DL
Clin Cancer Res; 2001 Apr; 7(4):1043-51. PubMed ID: 11309356
[TBL] [Abstract][Full Text] [Related]
22. Inositol hexaphosphate and paclitaxel: symbiotic treatment of oral cavity squamous cell carcinoma.
Janus SC; Weurtz B; Ondrey FG
Laryngoscope; 2007 Aug; 117(8):1381-8. PubMed ID: 17607147
[TBL] [Abstract][Full Text] [Related]
23. Cell cycle-dependent antagonistic interactions between paclitaxel and gamma-radiation in combination therapy.
Sui M; Dziadyk JM; Zhu X; Fan W
Clin Cancer Res; 2004 Jul; 10(14):4848-57. PubMed ID: 15269161
[TBL] [Abstract][Full Text] [Related]
24. [Apoptotic effect of the combined treatment of engineered antibody with paclitaxel on BT474 cells].
Yin HJ; Cheng LS; Duan JL
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Mar; 23(3):260-3. PubMed ID: 17343796
[TBL] [Abstract][Full Text] [Related]
25. In vitro schedule-dependent interaction between paclitaxel and oxaliplatin in human cancer cell lines.
Tanaka R; Ariyama H; Qin B; Takii Y; Baba E; Mitsugi K; Harada M; Nakano S
Cancer Chemother Pharmacol; 2005 Jun; 55(6):595-601. PubMed ID: 15731917
[TBL] [Abstract][Full Text] [Related]
26. In vitro sequence-dependent interaction between nedaplatin and paclitaxel in human cancer cell lines.
Tanaka R; Takii Y; Shibata Y; Ariyama H; Qin B; Baba E; Kusaba H; Mitsugi K; Harada M; Nakano S
Cancer Chemother Pharmacol; 2005 Sep; 56(3):279-85. PubMed ID: 15875187
[TBL] [Abstract][Full Text] [Related]
27. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH
Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169
[TBL] [Abstract][Full Text] [Related]
28. Differential effects of taxol on two human cancer cell lines.
Banerjee S; Fallis AG; Brown DL
Oncol Res; 1997; 9(5):237-48. PubMed ID: 9306431
[TBL] [Abstract][Full Text] [Related]
29. Pharmacodynamics of immediate and delayed effects of paclitaxel: role of slow apoptosis and intracellular drug retention.
Au JL; Li D; Gan Y; Gao X; Johnson AL; Johnston J; Millenbaugh NJ; Jang SH; Kuh HJ; Chen CT; Wientjes MG
Cancer Res; 1998 May; 58(10):2141-8. PubMed ID: 9605758
[TBL] [Abstract][Full Text] [Related]
30. RAIDD expression is impaired in multidrug resistant osteosarcoma cell lines.
Yang C; Hornicek FJ; Wood KB; Schwab JH; Mankin H; Duan Z
Cancer Chemother Pharmacol; 2009 Aug; 64(3):607-14. PubMed ID: 19125251
[TBL] [Abstract][Full Text] [Related]
31. Anthocyanins induce cell cycle perturbations and apoptosis in different human cell lines.
Lazzè MC; Savio M; Pizzala R; Cazzalini O; Perucca P; Scovassi AI; Stivala LA; Bianchi L
Carcinogenesis; 2004 Aug; 25(8):1427-33. PubMed ID: 15016660
[TBL] [Abstract][Full Text] [Related]
32. Effects of paclitaxel on permanent head and neck squamous cell carcinoma cell lines and identification of anti-apoptotic caspase 9b.
Maushagen R; Reers S; Pfannerstill AC; Hahlbrock A; Stauber R; Rahmanzadeh R; Rades D; Pries R; Wollenberg B
J Cancer Res Clin Oncol; 2016 Jun; 142(6):1261-71. PubMed ID: 27038158
[TBL] [Abstract][Full Text] [Related]
33. Head and neck cancer cell lines are resistant to mitochondrial-depolarization-induced apoptosis.
Zhao M; Mydlarz WK; Zhou S; Califano J
ORL J Otorhinolaryngol Relat Spec; 2008; 70(4):257-63. PubMed ID: 18483464
[TBL] [Abstract][Full Text] [Related]
34. Suberoylanilide hydroxamic acid (SAHA) potentiates paclitaxel-induced apoptosis in ovarian cancer cell lines.
Dietrich CS; Greenberg VL; DeSimone CP; Modesitt SC; van Nagell JR; Craven R; Zimmer SG
Gynecol Oncol; 2010 Jan; 116(1):126-30. PubMed ID: 19875160
[TBL] [Abstract][Full Text] [Related]
35. G2/M cell-cycle arrest and apoptosis by n-3 fatty acids in a pancreatic cancer model.
Dekoj T; Lee S; Desai S; Trevino J; Babcock TA; Helton WS; Espat NJ
J Surg Res; 2007 May; 139(1):106-12. PubMed ID: 17291531
[TBL] [Abstract][Full Text] [Related]
36. Enhanced apoptotic effects of novel paclitaxel analogs on NCI/ADR-RES breast cancer cells.
Yang LX; Zhu J; Wang HJ; Holton RA
Anticancer Res; 2003; 23(4):3295-301. PubMed ID: 12926066
[TBL] [Abstract][Full Text] [Related]
37. Cell-cycle progression and response of germ cell tumors to cisplatin in vitro.
Mueller S; Schittenhelm M; Honecker F; Malenke E; Lauber K; Wesselborg S; Hartmann JT; Bokemeyer C; Mayer F
Int J Oncol; 2006 Aug; 29(2):471-9. PubMed ID: 16820891
[TBL] [Abstract][Full Text] [Related]
38. Head and neck squamous cell carcinoma is highly sensitive to vinorelbine in Vitro.
Erjala K; Pulkkinen J; Kulmala J; Alanen K; Grenman R
Anticancer Res; 2002; 22(6A):3135-42. PubMed ID: 12530056
[TBL] [Abstract][Full Text] [Related]
39. In vitro concurrent paclitaxel and radiation of four vulvar squamous cell carcinoma cell lines.
Jaakkola M; Rantanen V; Grénman S; Kulmala J; Grénman R
Cancer; 1996 May; 77(9):1940-6. PubMed ID: 8646696
[TBL] [Abstract][Full Text] [Related]
40. Demethylating agent 5-aza-2'-deoxycytidine enhances susceptibility of renal cell carcinoma to paclitaxel.
Shang D; Ito N; Kamoto T; Ogawa O
Urology; 2007 May; 69(5):1007-12. PubMed ID: 17482960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
